(+)-Alloaromadendrene

Details

Top
Internal ID 44be5232-bf47-4764-ac6b-0867db34cb91
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Aromadendrane sesquiterpenoids > 5,10-cycloaromadendrane sesquiterpenoids
IUPAC Name (1aS,4aR,7S,7aS,7bR)-1,1,7-trimethyl-4-methylidene-2,3,4a,5,6,7,7a,7b-octahydro-1aH-cyclopropa[e]azulene
SMILES (Canonical) CC1CCC2C1C3C(C3(C)C)CCC2=C
SMILES (Isomeric) C[C@H]1CC[C@@H]2[C@H]1[C@@H]3[C@@H](C3(C)C)CCC2=C
InChI InChI=1S/C15H24/c1-9-6-8-12-14(15(12,3)4)13-10(2)5-7-11(9)13/h10-14H,1,5-8H2,2-4H3/t10-,11-,12-,13-,14-/m0/s1
InChI Key ITYNGVSTWVVPIC-PEDHHIEDSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24
Molecular Weight 204.35 g/mol
Exact Mass 204.187800766 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 4.70
Atomic LogP (AlogP) 4.27
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
[-]-Isoaromadendrene[V]
ITYNGVSTWVVPIC-PEDHHIEDSA-N
NSC751207
NSC-751207

2D Structure

Top
2D Structure of (+)-Alloaromadendrene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9883 98.83%
Caco-2 + 0.7657 76.57%
Blood Brain Barrier + 0.9500 95.00%
Human oral bioavailability + 0.6286 62.86%
Subcellular localzation Lysosomes 0.7069 70.69%
OATP2B1 inhibitior - 0.8476 84.76%
OATP1B1 inhibitior + 0.8678 86.78%
OATP1B3 inhibitior + 0.9419 94.19%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior - 0.9662 96.62%
P-glycoprotein inhibitior - 0.9021 90.21%
P-glycoprotein substrate - 0.9018 90.18%
CYP3A4 substrate + 0.5519 55.19%
CYP2C9 substrate - 0.7890 78.90%
CYP2D6 substrate - 0.7441 74.41%
CYP3A4 inhibition - 0.9119 91.19%
CYP2C9 inhibition - 0.6547 65.47%
CYP2C19 inhibition - 0.6360 63.60%
CYP2D6 inhibition - 0.9224 92.24%
CYP1A2 inhibition - 0.6302 63.02%
CYP2C8 inhibition - 0.5778 57.78%
CYP inhibitory promiscuity - 0.7777 77.77%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7000 70.00%
Carcinogenicity (trinary) Non-required 0.4839 48.39%
Eye corrosion - 0.9009 90.09%
Eye irritation + 0.7826 78.26%
Skin irritation + 0.5956 59.56%
Skin corrosion - 0.9729 97.29%
Ames mutagenesis - 0.8170 81.70%
Human Ether-a-go-go-Related Gene inhibition + 0.6615 66.15%
Micronuclear - 0.9000 90.00%
Hepatotoxicity + 0.7000 70.00%
skin sensitisation + 0.7747 77.47%
Respiratory toxicity - 0.5444 54.44%
Reproductive toxicity - 0.7222 72.22%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity + 0.6714 67.14%
Acute Oral Toxicity (c) III 0.8388 83.88%
Estrogen receptor binding - 0.5504 55.04%
Androgen receptor binding + 0.5731 57.31%
Thyroid receptor binding - 0.7144 71.44%
Glucocorticoid receptor binding - 0.6636 66.36%
Aromatase binding - 0.7796 77.96%
PPAR gamma - 0.8262 82.62%
Honey bee toxicity - 0.7820 78.20%
Biodegradation - 0.5500 55.00%
Crustacea aquatic toxicity + 0.8900 89.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.62% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 89.64% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.50% 97.09%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 86.93% 86.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.46% 96.09%
CHEMBL241 Q14432 Phosphodiesterase 3A 86.19% 92.94%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.53% 100.00%
CHEMBL221 P23219 Cyclooxygenase-1 80.61% 90.17%
CHEMBL5608 Q16288 NT-3 growth factor receptor 80.51% 95.89%
CHEMBL1871 P10275 Androgen Receptor 80.01% 96.43%

Cross-Links

Top
PubChem 21775889
NPASS NPC41385
LOTUS LTS0078593
wikiData Q105120409